Pharmacological action

Combined antibacterial drug for external use. Contains two antibiotics, which have a bactericidal effect, neomycin and bacitracin.

Bacitracin is a polypeptide antibiotic that inhibits the synthesis of the bacterial cell membrane. Bacitracin is active against gram-positive microorganisms, such as β-hemolytic streptococci, staphylococci, and some gram-negative pathogens. Resistance to bacitracin is extremely rare.

Neomycin is an antibiotic-aminoglycoside, which inhibits the synthesis of bacterial proteins. It is active against gram-positive and gram-negative bacteria.

By using a combination of these two antibiotics, a broad spectrum of action of the drug is achieved and synergism of action against a number of microorganisms, for example, staphylococci.

Indications

Treatment of infectious and inflammatory skin diseases caused by microorganisms sensitive to the preparation:

- focal skin infections, incl. furuncles, carbuncles (after surgical treatment), staphylococcus sycosis, periporitis, deep folliculitis, purulent hydradenitis, paronychia;

- bacterial skin infections of limited prevalence, incl. contagious impetigo, infected ulcers of the lower extremities, secondarily infected eczema, secondary infection with dermatoses, cuts, abrasions, burns, cosmetic surgery and skin transplantation (also for prevention and for dressing).

Preventive maintenance and treatment of an infection after surgical interventions. Ointment Baneocin® can be used as an additional treatment in the postoperative period. Applying the ointment to the bandages is preferable in the local treatment of patients with infected cavities and wounds (for example, bacterial infections of the external auditory canal without perforation of the tympanic membrane, wounds or surgical incisions healing with secondary tension).